DK0841946T4 - Metoder til behandling af allergisk astma - Google Patents

Metoder til behandling af allergisk astma

Info

Publication number
DK0841946T4
DK0841946T4 DK96926134T DK96926134T DK0841946T4 DK 0841946 T4 DK0841946 T4 DK 0841946T4 DK 96926134 T DK96926134 T DK 96926134T DK 96926134 T DK96926134 T DK 96926134T DK 0841946 T4 DK0841946 T4 DK 0841946T4
Authority
DK
Denmark
Prior art keywords
treatment
methods
allergic asthma
asthma
allergic
Prior art date
Application number
DK96926134T
Other languages
English (en)
Other versions
DK0841946T3 (da
Inventor
Steven J Shire
Robert B Fick Jr
Paula M Jardieu
Monika B Schoenhoff
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24021032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0841946(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0841946T3 publication Critical patent/DK0841946T3/da
Publication of DK0841946T4 publication Critical patent/DK0841946T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96926134T 1995-07-27 1996-07-24 Metoder til behandling af allergisk astma DK0841946T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50801495A 1995-07-27 1995-07-27
PCT/US1996/012275 WO1997004807A1 (en) 1995-07-27 1996-07-24 Methods for treatment of allergic asthma

Publications (2)

Publication Number Publication Date
DK0841946T3 DK0841946T3 (da) 2003-02-10
DK0841946T4 true DK0841946T4 (da) 2009-02-16

Family

ID=24021032

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96926134T DK0841946T4 (da) 1995-07-27 1996-07-24 Metoder til behandling af allergisk astma

Country Status (16)

Country Link
EP (1) EP0841946B2 (da)
JP (1) JP4153560B2 (da)
CN (2) CN101172100A (da)
AR (1) AR003468A1 (da)
AT (1) ATE225185T1 (da)
AU (1) AU715338B2 (da)
CA (1) CA2226624C (da)
DE (1) DE69624116T3 (da)
DK (1) DK0841946T4 (da)
ES (1) ES2186796T5 (da)
IL (1) IL122733A (da)
MX (1) MX9800760A (da)
PT (1) PT841946E (da)
RU (1) RU2229288C2 (da)
WO (1) WO1997004807A1 (da)
ZA (2) ZA966075B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
US6991790B1 (en) 1997-06-13 2006-01-31 Genentech, Inc. Antibody formulation
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
AU3065999A (en) * 1998-03-10 1999-09-27 Children's Hospital Of Philadelphia, The Compositions and methods for treatment of asthma
US6299875B1 (en) * 1998-06-04 2001-10-09 Panacea Pharmaceuticals, Llc Methods to block IGE binding to cell surface receptors of mast cells
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
AU1344102A (en) * 2000-10-12 2002-04-22 Genentech Inc Reduced-viscosity concentrated protein formulations
US8703126B2 (en) 2000-10-12 2014-04-22 Genentech, Inc. Reduced-viscosity concentrated protein formulations
AU2003286002B2 (en) 2002-11-08 2011-06-16 Ablynx N.V. Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
NZ540196A (en) 2002-11-08 2008-09-26 Ablynx Nv Camelidae antibodies against imminoglobulin E and use thereof for the treatment of allergic disorders
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
DE202006020194U1 (de) * 2006-03-01 2007-12-06 Bioceuticals Arzneimittel Ag G-CSF-Flüssigformulierung
NZ577858A (en) * 2007-01-29 2012-02-24 Valtion Teknillinen Method for producing novel ige based reagents
AR065368A1 (es) 2007-02-15 2009-06-03 Astrazeneca Ab Anticuerpos para moleculas de ige
EP2052736A1 (en) * 2007-10-26 2009-04-29 Nycomed Danmark ApS Parathyroid hormone formulations und uses thereof
NZ585516A (en) * 2007-12-21 2012-07-27 Hoffmann La Roche Anti-cd20 antibody formulation
PT2222315E (pt) * 2007-12-21 2013-07-16 Cangene Corp Formulações de fator ix estabilizadas contendo trealose
AU2009314311B2 (en) 2008-10-29 2013-01-10 Ablynx N.V. Methods for purification of single domain antigen binding molecules
AR073997A1 (es) * 2008-10-29 2010-12-15 Wyeth Corp Formulaciones de moleculas de union a antigeno de dominio unico. metodo. kit
CN102711733A (zh) 2009-12-15 2012-10-03 阿森迪斯药物股份有限公司 瞬时连接于聚合物载体的干生长激素组合物
CN102533704A (zh) * 2010-12-30 2012-07-04 上海雅心生物技术有限公司 即配即用型的胰蛋白酶制剂
PL2691112T3 (pl) * 2011-03-31 2018-09-28 Merck Sharp & Dohme Corp. Stabilne preparaty przeciwciał przeciw ludzkiemu receptorowi programowanej śmierci pd-1 i terapie powiązane
AU2012328739B2 (en) * 2011-10-25 2017-11-30 Prothena Biosciences Limited Antibody formulations and methods
JP6549104B2 (ja) * 2013-09-27 2019-07-24 ハンミ ファーマシューティカル カンパニー リミテッド 持続型ヒト成長ホルモン製剤
CN104707146B (zh) * 2013-12-16 2019-04-16 浙江海正药业股份有限公司 一种含有阿达木单抗的药物组合物
GB201610198D0 (en) 2016-06-10 2016-07-27 Ucb Biopharma Sprl Anti-ige antibodies
JP7382232B2 (ja) 2017-05-02 2023-11-16 メルク・シャープ・アンド・ドーム・エルエルシー 抗ｌａｇ３抗体の製剤および抗ｌａｇ３抗体と抗ｐｄ－１抗体との共製剤
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
ES2950570T3 (es) 2017-07-25 2023-10-11 Jiangsu Hengrui Medicine Co Composición farmacéutica del complejo de proteína il-15 y usos de la misma
CN110732023B (zh) * 2018-07-18 2023-06-16 江苏恒瑞医药股份有限公司 一种her2抗体药物组合物及其用途
CA3185192A1 (en) 2020-07-10 2022-01-13 Sujun DENG Anti-ige engineered antibody and application thereof
TW202409078A (zh) * 2022-07-18 2024-03-01 中國大陸商蘇州創勝醫藥集團有限公司 穩定之包含抗gremlin1抗體的藥物製劑

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3729863A1 (de) * 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate
AU616916B2 (en) * 1987-11-20 1991-11-14 Kissei Pharmaceutical Co. Ltd. 4h-quinolizin-4-one compounds exhibiting therapeutic activities
AU618317B2 (en) * 1987-12-31 1991-12-19 Tanox Biosystems, Inc. Unique antigenic epitopes on ige-bearing b lymphocytes
AU3923293A (en) * 1992-03-20 1993-10-21 Immunet Human monoclonal antibodies and methods for human monoclonal antibody production
JPH07118168A (ja) * 1993-10-19 1995-05-09 Tomoyasu Ra ＩｇＥ産生抑制剤
PT589840E (pt) * 1992-09-24 2004-08-31 Tanox Biosystems Inc Anticorpos monoclonais reformulados contra um isotipo de imunoglobulina
DE4344824C1 (de) * 1993-12-28 1995-08-31 Immuno Ag Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
IL122733A0 (en) 1998-08-16
AU6638196A (en) 1997-02-26
EP0841946A1 (en) 1998-05-20
AU715338B2 (en) 2000-01-20
ES2186796T5 (es) 2009-04-01
IL122733A (en) 2001-09-13
JPH11510172A (ja) 1999-09-07
DK0841946T3 (da) 2003-02-10
CA2226624A1 (en) 1997-02-13
CA2226624C (en) 2013-07-16
ZA966240B (en) 1998-01-23
CN101172100A (zh) 2008-05-07
ES2186796T3 (es) 2003-05-16
AR003468A1 (es) 1998-08-05
MX9800760A (es) 1998-04-30
PT841946E (pt) 2003-02-28
EP0841946B1 (en) 2002-10-02
RU2229288C2 (ru) 2004-05-27
DE69624116T2 (de) 2003-06-18
JP4153560B2 (ja) 2008-09-24
ZA966075B (en) 1998-01-19
WO1997004807A1 (en) 1997-02-13
CN101172099A (zh) 2008-05-07
DE69624116T3 (de) 2009-07-09
CN101172099B (zh) 2012-02-15
DE69624116D1 (de) 2002-11-07
ATE225185T1 (de) 2002-10-15
EP0841946B2 (en) 2008-10-15

Similar Documents

Publication Publication Date Title
DK0841946T4 (da) Metoder til behandling af allergisk astma
DK0820276T3 (da) Fremgangsmåde til fremstilling af respirerbare partikler
NO993847D0 (no) Fremgangsmåter og sammensetninger for behandling av allergisk astma og andre sykdommer som anvender deskarboetoksyloratadin
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
ATE300938T1 (de) Ulmwh (ultra-low-molecular weight heparin) zur behandlung von asthma
NO991955D0 (no) FremgangsmÕte for behandling av hydrokarboner
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
DK0785792T3 (da) Præparat til behandling af ovariale af østrogen afhængige sygdomme
DK0775100T3 (da) Fremgangsmåde til fremstilling af trifluorethylen
DK0756597T3 (da) Fremgangsmåde til fremstilling af puriner
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
EE200200632A (et) Glükokortikoidravimeid sisaldavad preparaadid bronhopulmonaalsete haiguste raviks
BR9609053A (pt) Métodos de induzir fator de transcrição de bef-1
DK0912603T3 (da) Fremgangsmåde til fremstilling af visse azacyclohexapeptider
DK0819113T3 (da) Benzamider til behandling af neurodegenerative forstyrrelser
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
DK0648738T3 (da) Fremgangsmåde til fremstilling af acetoacetarylamider
DK0554691T3 (da) Fremgangsmåde til behandling af røggas
DK0721929T3 (da) Fremgangsmåde til fremstilling af hydroxyalkoxybenzophenoner
DK0863874T3 (da) Fremgangsmåde til fremstilling af dioxoazabicyclohexaner
NO972682D0 (no) Ny fremgangsmåte for fremstilling av sameridin
NO964291D0 (no) Fremgangsmåte for behandling av allergisk rinitt
DK110593D0 (da) Anlaeg til kontinuerlig behandling af ostemasse
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod